Figure 3From: Patan hospital experience in treating philadelphia chromosome/BCR-ABL1 positive chronic myeloid leukemia patients with gleevec (imatinib mesylate); the first generation specific tyrosine kinase inhibitor Kaplan-Meier of survival based on gender. The survival of patients, based on gender is shown.Back to article page